List of Excipients in API dextromethorphan hydrobromide, guaifenesin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dextromethorphan hydrobromide, guaifenesin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Navajo Manufacturing Company Inc | MUCINEX DM | dextromethorphan hydrobromide, guaifenesin | 67751-171 | CARBOMER HOMOPOLYMER TYPE B | |
| Navajo Manufacturing Company Inc | MUCINEX DM | dextromethorphan hydrobromide, guaifenesin | 67751-171 | CELLULOSE, MICROCRYSTALLINE | |
| Navajo Manufacturing Company Inc | MUCINEX DM | dextromethorphan hydrobromide, guaifenesin | 67751-171 | D&C YELLOW NO. 10 | |
| Navajo Manufacturing Company Inc | MUCINEX DM | dextromethorphan hydrobromide, guaifenesin | 67751-171 | HYPROMELLOSE | |
| Navajo Manufacturing Company Inc | MUCINEX DM | dextromethorphan hydrobromide, guaifenesin | 67751-171 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dextromethorphan hydrobromide, guaifenesin
Detailed excipient profiles for dextromethorphan hydrobromide, guaifenesin
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
dextromethorphan hydrobromide, guaifenesin drug variants containing CARBOMER HOMOPOLYMER TYPE B
dextromethorphan hydrobromide, guaifenesin drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dextromethorphan hydrobromide, guaifenesin drug variants containing CELLULOSE, MICROCRYSTALLINE
dextromethorphan hydrobromide, guaifenesin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
dextromethorphan hydrobromide, guaifenesin drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | dextromethorphan hydrobromide, guaifenesin | 0280-1660 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, guaifenesin drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
dextromethorphan hydrobromide, guaifenesin drug variants containing COPOVIDONE K25-31
dextromethorphan hydrobromide, guaifenesin drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC | dextromethorphan hydrobromide, guaifenesin | 0280-1660 |
| Navajo Manufacturing Company Inc | dextromethorphan hydrobromide, guaifenesin | 67751-171 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
dextromethorphan hydrobromide, guaifenesin drug variants containing D&C YELLOW NO. 10
dextromethorphan hydrobromide, guaifenesin drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
dextromethorphan hydrobromide, guaifenesin drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
dextromethorphan hydrobromide, guaifenesin drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: HYPROMELLOSE
dextromethorphan hydrobromide, guaifenesin drug variants containing HYPROMELLOSE
dextromethorphan hydrobromide, guaifenesin drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | dextromethorphan hydrobromide, guaifenesin | 0113-7419 |
| Bayer HealthCare LLC | dextromethorphan hydrobromide, guaifenesin | 0280-1660 |
| Big Lots Stores Inc | dextromethorphan hydrobromide, guaifenesin | 50594-812 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dextromethorphan hydrobromide, guaifenesin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | dextromethorphan hydrobromide, guaifenesin | 0113-7419 |
| Bayer HealthCare LLC | dextromethorphan hydrobromide, guaifenesin | 0280-1660 |
| Big Lots Stores Inc | dextromethorphan hydrobromide, guaifenesin | 50594-812 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, guaifenesin drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM HYDROXIDE
dextromethorphan hydrobromide, guaifenesin drug variants containing MAGNESIUM HYDROXIDE
dextromethorphan hydrobromide, guaifenesin drug variants not containing MAGNESIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Navajo Manufacturing Company Inc | dextromethorphan hydrobromide, guaifenesin | 67751-171 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dextromethorphan hydrobromide, guaifenesin drug variants containing MAGNESIUM STEARATE
dextromethorphan hydrobromide, guaifenesin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA
dextromethorphan hydrobromide, guaifenesin drug variants containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dextromethorphan hydrobromide, guaifenesin | 50090-7891 |
| >Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, guaifenesin drug variants not containing SILICA
Excipient focus: SILICON DIOXIDE
dextromethorphan hydrobromide, guaifenesin drug variants containing SILICON DIOXIDE
dextromethorphan hydrobromide, guaifenesin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | dextromethorphan hydrobromide, guaifenesin | 50090-7891 |
| Navajo Manufacturing Company Inc | dextromethorphan hydrobromide, guaifenesin | 67751-171 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch